Lexaria will license in any of the 40 countries where its technology already has a patent or is patent-pending Company sees up to 80 percent of its future revenues coming from licensing DehydraTECH proprietary ingestion delivery technology DehydraTECH™ has applications for processed foods, tobacco industry, pharmaceutical companies, NSAIDs, supplements and beverages Lexaria Bioscience Corp. (CSE: […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.